Article
IFN-λ4 potently blocks IFN-α signalling by ISG15 and USP18 in hepatitis C virus infection
13 Jun 2017
Abstract excerpt
Genetic polymorphisms in IFNL4 have been shown to predict responses to IFN-α-based therapy in hepatitis C virus (HCV)-infected patients. The IFNL4-ΔG genotype, which encodes functional IFN-λ4 protein, is associated with a poor treatment response. In the present study, we investigated the induction and biological effects of IFN-λ4 in HCV-infected hepatocytes and their association with responsiveness to IFN-α. We...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
